Skip to main content

Table 3 Features of creatine kinase in 14 patients with LCHADD - patients grouped by mode of diagnosis (see Table 1 and 2 )

From: Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD)

Patient

n CK

max CK (in U/l)

max CK (age)

n CK >1,000 (in U/l)

1

57

40,381

16.2 y

19

2

127

34,160

4.2 y

31

3

36

39,501

5.8 y

10

4

132

10,170

1.9 y

19

5

67

8,876

3.9 y

17

6

15

299

0.8 y

0

7

52

62,216

2.7 y

6

8

69

73,260

0.9 y

27

9

22

95,000

2.7 y

8

10

71

67,500

2.6 y

14

11

29

68,600

0.6 y

6

12

26

12,000

2.1 y

8

13

9

449

1.7 y

0

14

10

725

2 d

0

Median

44

40,381

2.35 y

14

  1. (n CK) number of CK measurements, (max CK (in U/l)) highest measured CK, (max CK (age)) age when highest CK was measured, (n CK > 1,000) number of CK measurements >1,000 U/l, (y) years.
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172